Stocksigma LogoStocksigma Logo

Natco Pharma FY26 Sustainability Report Highlights Key Operational Metrics and Targets

Natco Pharma generated standalone turnover of ₹35,946 mn and net worth of ₹85,526 mn in FY25-26, with exports contributing 74%

Natco Pharma FY26 Sustainability Report Highlights Key Operational Metrics and Targets

Natco Pharma Ltd · Others (Uncategorized) · 05 Sept 2026, 2:02 am

Natco Pharma FY26 Sustainability Report Highlights Key Operational Metrics and Targets Natco Pharma generated standalone turnover of ₹35,946 mn and net worth of ₹85,526 mn in FY25-26, with exports contributing 74%. R&D investments reached ₹4,086 mn (10.5% of total), while capital expenditure dedicated to environmental impact was ₹74.2 mn. Scope 1 and Scope 2 GHG emissions totaled 68,389 tCO2e, with an emission intensity of 1.677 tCO2e/₹ mn turnover. Renewable energy comprised 18.47% of total energy use, progressing toward a 35% target by 2035 and net-zero by 2050. Accounts payable stood at 160 days.

Original exchange filing (PDF)

More announcements from Natco Pharma Ltd

All Natco Pharma Ltd announcements